Variation in staging and treatment of local and regional breast cancer in the elderly

[1]  S. Edge,et al.  Treatment of early-stage breast cancer. , 1999, Current problems in cancer.

[2]  B E Hillner,et al.  Factors that determine the treatment for local and regional prostate cancer. , 1996, Medical care.

[3]  S. Joslyn.  Racial differences in survival from breast cancer. , 1995, JAMA.

[4]  C K Redmond,et al.  Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. , 1994, JAMA.

[5]  E. Sondik,et al.  Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D McLerran,et al.  Using administrative data to describe casemix: a comparison with the medical record. , 1994, Journal of clinical epidemiology.

[7]  D. Hynes.  The Quality of Breast Cancer Care in Local Communities: Implications for Health Care Reform , 1994, Medical care.

[8]  J P Kassirer,et al.  The quality of care and the quality of measuring it. , 1993, The New England journal of medicine.

[9]  E. DeLong,et al.  Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research , 1993, Annals of Internal Medicine.

[10]  A. Luini,et al.  Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. , 1993, The New England journal of medicine.

[11]  W. Willett,et al.  Breast cancer (2). , 1992, The New England journal of medicine.

[12]  J. Samet,et al.  Geographic variation in the treatment of localized breast cancer. , 1992, The New England journal of medicine.

[13]  A B Nattinger,et al.  Geographic variation in the use of breast-conserving treatment for breast cancer. , 1992, The New England journal of medicine.

[14]  Early Breast Cancer Trialists' Collaborative Group.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992, The Lancet.

[15]  J. Chmiel,et al.  Hospital variables associated with quality of care for breast cancer patients. , 1991, JAMA.

[16]  Stephen E. Jones.  Implications of the NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer , 1991 .

[17]  R. Gelber,et al.  Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Rubin,et al.  Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. , 1988, International journal of radiation oncology, biology, physics.

[19]  R. Elashoff,et al.  Patterns of care related to age of breast cancer patients. , 1987, JAMA.

[20]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[21]  M. Laberge.  [Cancer of the breast]. , 1961, Laval medical.

[22]  C. Eggers,et al.  CANCER OF THE BREAST , 1941, Annals of surgery.

[23]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[24]  H Volk,et al.  Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Early Breast Cancer Trialists' Collaborative Group.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992, Lancet.

[26]  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992, Lancet.

[27]  L L Roos,et al.  Comparing clinical information with claims data: some similarities and differences. , 1991, Journal of clinical epidemiology.

[28]  C. Boring,et al.  Cancer statistics, 1990 , 1990, CA: a cancer journal for clinicians.

[29]  Jack Cuzick,et al.  Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.